Thursday, March 16, 2017 1:30:52 PM
http://ih.advfn.com/p.php?pid=nmona&article=74081598&symbol=VBIO
Item 1.01. Entry into a Material Definitive Agreement.
On March 9, 2017, Vitality Biopharma, Inc., a Nevada corporation (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain accredited investors (the “Purchasers”), pursuant to which the Company issued to the Purchasers an aggregate of 1,500,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a price of US$1.00 per share, for the aggregate purchase price of US$1,500,000.00 (the “Purchase Price”), which closed on March 9, 2017. The Securities Purchase Agreement contains customary representations, warranties, covenants and conditions for agreements of this type. The Company is not required to file a registration statement covering these securities.
Recent RNGE News
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 05/08/2024 06:54:30 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM